Hobart Private Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,877
| Closed | -$269K | – | 121 |
|
|
2021
Q2 | $269K | Sell |
6,877
-696
| -9% | -$27.3K | 0.11% | 108 |
|
|
2021
Q1 | $274K | Sell |
7,573
-4,544
| -38% | -$165K | 0.11% | 112 |
|
|
2020
Q4 | $446K | Sell |
12,117
-5,704
| -32% | -$210K | 0.2% | 93 |
|
|
2020
Q3 | $621K | Sell |
17,821
-16,037
| -47% | -$558K | 0.32% | 56 |
|
|
2020
Q2 | $1.05M | Sell |
33,858
-14,282
| -30% | -$443K | 0.59% | 36 |
|
|
2020
Q1 | $1.49M | Sell |
48,140
-6,788
| -12% | -$210K | 1.02% | 23 |
|
|
2019
Q4 | $2.04M | Buy |
54,928
+25,873
| +89% | +$962K | 1.25% | 18 |
|
|
2019
Q3 | $990K | Buy |
29,055
+17,574
| +153% | +$599K | 0.68% | 43 |
|
|
2019
Q2 | $472K | Buy |
11,481
+4,795
| +72% | +$197K | 0.33% | 66 |
|
|
2019
Q1 | $269K | Sell |
6,686
-1,202
| -15% | -$48.4K | 0.2% | 123 |
|
|
2018
Q4 | $327K | Sell |
7,888
-13,990
| -64% | -$579K | 0.28% | 85 |
|
|
2018
Q3 | $915K | Sell |
21,878
-1,385
| -6% | -$57.9K | 0.7% | 46 |
|
|
2018
Q2 | $801K | Buy |
23,263
+11,419
| +96% | +$393K | 0.65% | 52 |
|
|
2018
Q1 | $399K | Buy |
+11,844
| New | +$399K | 0.35% | 81 |
|